Equities

DKSH Holding AG

DKSH Holding AG

Actions
  • Price (CHF)64.80
  • Today's Change-0.10 / -0.15%
  • Shares traded24.00
  • 1 Year change+16.59%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024 09:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DKSH Holding AG is a Switzerland-based company that provides market expansion services. The Company’s business activities are divided into four business units: Consumer Goods, Healthcare, Performance Materials, and Technology. The Consumer Goods business unit focuses on fast moving consumer goods, food services, luxury and lifestyle products in Asia. The Healthcare business unit provides market expansion services for healthcare companies seeking to grow their business in Asia. The Performance Materials business unit offers instant access to raw materials around the world, serving the chemical, pharmaceutical, food, beverage and personal care industries. The Technology business unit offers its customers a range of technologies from European, American and Asian manufacturers with a focus on advanced machinery for industry and construction, analytical and scientific instruments, components and consumables. The Company is the parent company of DKSH Group and operates numerous subsidiaries.

  • Revenue in CHF (TTM)10.88bn
  • Net income in CHF189.80m
  • Incorporated1932
  • Employees26.40k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DKSH:SWX since
announced
Transaction
value
Medipharm Sdn BhdAnnounced15 Jan 202415 Jan 2024Announced13.46%--
Data delayed at least 15 minutes, as of Nov 22 2024 09:25 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.